SAINTS CAPITAL GRANITE, L.P.

Average Profitability
19.31%
Insider Buys Quantity
1
Insider Buys Sum
$1.86M
Insider Sells Quantity
8
Insider Sells Sum
$12.83M

Insider Activity of SAINTS CAPITAL GRANITE, L.P.

The largest purchase of all time was on 2013-03-26 and amounted to 132948 shares of Enanta Pharmaceuticals, Inc. for $1.86M.

The largest sale of all time was on 2013-10-01 and amounted to 371400 shares of Enanta Pharmaceuticals, Inc. for $8.74M.

Biography of SAINTS CAPITAL GRANITE, L.P.

No biography is available at this moment.

2013-10-14SaleEnanta Pharmaceuticals, Inc.
ENTA
10 percent owner
64,206
0.3637%
$19.83$1.27M+96.05%
2013-10-11SaleEnanta Pharmaceuticals, Inc.
ENTA
10 percent owner
396
0.0023%
$21.05$8,336+85.26%
2013-10-10SaleEnanta Pharmaceuticals, Inc.
ENTA
10 percent owner
22,414
0.1257%
$21.06$471,956+82.55%
2013-10-09SaleEnanta Pharmaceuticals, Inc.
ENTA
10 percent owner
50,000
0.2981%
$22.00$1.1M+85.6%
2013-10-03SaleEnanta Pharmaceuticals, Inc.
ENTA
10 percent owner
8,200
0.0459%
$22.85$187,337+66.67%
2013-10-02SaleEnanta Pharmaceuticals, Inc.
ENTA
10 percent owner
16,400
0.0929%
$23.66$387,993+62.7%
2013-10-01SaleEnanta Pharmaceuticals, Inc.
ENTA
10 percent owner
371,400
2.0544%
$23.54$8.74M+59.11%
2013-09-30SaleEnanta Pharmaceuticals, Inc.
ENTA
10 percent owner
28,600
0.1608%
$23.13$661,512+63.74%
2013-03-26PurchaseEnanta Pharmaceuticals, Inc.
ENTA
10 percent owner
132,948
4.9675%
$14.00$1.86M+19.31%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.